Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAstrazeneca plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | $2.44 | $2.72 | $2.52 |
| Q2 2026 | 2 | $2.47 | $2.52 | $2.48 |
| Q3 2026 | 2 | $2.59 | $2.68 | $2.63 |
| Q4 2026 | 1 | $2.41 | $2.50 | $2.46 |
| Q1 2027 | 1 | $2.78 | $2.88 | $2.83 |
| Q2 2027 | 1 | $2.72 | $2.82 | $2.77 |
| Q3 2027 | 1 | $3.04 | $3.16 | $3.10 |
| Q4 2027 | 1 | $2.60 | $2.70 | $2.65 |
Astrazeneca plc Earnings Date And Information
Astrazeneca plc last posted its earnings results on Monday, July 27th, 2026. The company reported $2.63 earnings per share for the quarter, topping analysts' consensus estimates of $2.5 by $0.13. The company had revenue of 15.38 B for the quarter and had revenue of 58.74 B for the year. Astrazeneca plc has generated $7 earnings per share over the last year ($6.54 diluted earnings per share) and currently has a price-to-earnings ratio of 23.16. Astrazeneca plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Astrazeneca plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/27/2026 | Q2 2026 | $2.50 | $1.60 | -0.9 | $15.44 B | $15.38 B |
| 04/29/2026 | Q1 2026 | $2.57 | $1.99 | -0.58 | $14.93 B | $15.29 B |
| 02/24/2026 | Q4 2025 | N/A | $1.51 | N/A | $15.44 B | $15.50 B |
| 11/06/2025 | Q3 2025 | $2.28 | $1.63 | -0.65 | $14.78 B | $15.19 B |
| 07/29/2025 | Q2 2025 | $2.18 | $1.58 | -0.6 | $14.10 B | $14.46 B |
| 03/30/2025 | Q1 2025 | N/A | $1.88 | N/A | $13.81 B | $13.59 B |
| 12/31/2024 | Q4 2024 | N/A | $0.97 | N/A | $14.23 B | $14.89 B |
| 09/30/2024 | Q3 2024 | N/A | $0.92 | N/A | $13.08 B | $13.57 B |
| 06/29/2024 | Q2 2024 | N/A | $0.62 | N/A | $12.62 B | $12.94 B |
| 03/30/2024 | Q1 2024 | N/A | $1.41 | N/A | $11.80 B | $12.68 B |
| 12/30/2023 | Q4 2023 | N/A | $0.61 | N/A | $12.08 B | $12.02 B |
| 09/29/2023 | Q3 2023 | N/A | $0.89 | N/A | $11.55 B | $11.49 B |
| 06/29/2023 | Q2 2023 | N/A | $1.17 | N/A | $11.01 B | $11.42 B |
| 03/31/2023 | Q1 2023 | N/A | $1.16 | N/A | $10.60 B | $10.88 B |
| 12/30/2022 | Q4 2022 | N/A | $0.58 | N/A | $11.25 B | $11.21 B |
| 09/29/2022 | Q3 2022 | N/A | $1.06 | N/A | $10.79 B | $10.98 B |
| 06/29/2022 | Q2 2022 | N/A | $0.23 | N/A | $10.45 B | $10.77 B |
| 03/30/2022 | Q1 2022 | N/A | $0.25 | N/A | $10.81 B | $11.39 B |
| 12/30/2021 | Q4 2021 | N/A | -$0.22 | N/A | $11.11 B | $12.01 B |
| 09/29/2021 | Q3 2021 | N/A | -$1.10 | N/A | $9.52 B | $9.87 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Astrazeneca plc Earnings: FAQ's
In the previous quarter, Astrazeneca plc (:AZN) reported $2.63 earnings per share (EPS) to beat the analysts' consensus estimate of $2.5 by $0.13.
The conference call for Astrazeneca plc's latest earnings report can be listened to online.
The conference call transcript for Astrazeneca plc's latest earnings report can be read online.
Astrazeneca plc (:AZN) has a recorded annual revenue of $58.74 B.
Astrazeneca plc (:AZN) has a recorded net income of $10.26 B.Astrazeneca plc has generated $6.6 earnings per share over the last four quarters.
Astrazeneca plc (:AZN) has a price-to-earnings ratio of 23.16 and price/earnings-to-growth ratio is 0.98.